baber/WOPTO huggingface dataset:
Patent JP-H0365944-B2 (JP)
IPC: C12P19/62
Filed: 1982-01-09
Abstract: The fermentation of a substrate selected among erythronolide B, erythronolide A and erythronolide A oxime with a novel mutant, Streptomyces antibioticus ATCC 31771, obtained from an industrial stock for the production of oleandomycin, said novel mutant being incapable of producing the same oleandomycin, permits novel macrolide antibiotics to be produced, having not only an activity range like that of erythromycin, but characterized by a greater stability in acidic environment, whereby for the administration of the antibiotic it is no longer necessary to have recourse to esters and/or salts highly toxic for the organism.
Patent JP-4878665-B2 (JP)
IPC: A01N1/00
Filed: 1998-01-08
Granted: 2012-02-15
Abstract: There is claimed herein, a method of conserving organic and inorganic materials comprising the step of impregnating a material selected from organic or inorganic materials with an organosilicon compound, or a mixture of organosilicon compounds, and thereafter initiating curing of the resultant product. If said material initially contains moisture or body fluids, such as blood, this method may further comprise an initial step of dehydrating the selected material in a dehydration step using an acetone bath before conducting said impregnation step.
Patent JP-H0515725-B2 (JP)
IPC: C08F283/12
Filed: 1983-01-13
Abstract: A graft copolymer dispersion is produced by polymerizing a mixture comprising by weight approximately (a) 1 to 99% of an organopolysiloxane mass containing Si-H groups and vinyl groups, and (b) 99 to 1% of a polymerizable vinyl monomer. Polymerization initiators and/or molecular weight controllers may also be present. The product is not crosslinked as produced but can be blended with a crosslinking agent, applied to a textile as a coating and the crosslinked.
Patent JP-3065577-B2 (JP)
IPC: H01L21/8247
Filed: 1998-01-20
Granted: 2000-07-17
Abstract: A densely packed array of vertical semiconductor devices having pillars and methods of making thereof are disclosed. The array has columns of bitlines and rows of wordlines. The gates of the transistors act as the wordlines, while the source or drain regions acts as the bitlines. The array also has vertical pillars, each having a channel formed between source and drain regions. Two transistors are formed per pillar. This is achieved by forming two gates per pillar formed on opposite pillar sidewalls which are along the bitline direction. This forms two wordlines or gates per pillar arranged in the wordline direction. The source regions are self-aligned and located below the pillars. The source regions of adjacent bit lines are isolated from each other without increasing the cell size.
Patent MD-1743-B2 (MD)
Title: Indole derivatives, process for preparation thereof, fungicidal composition and process for fungi control
Inventor: Curtze Jürgen
IPC: A01N43/38
Filed: 1993-06-03
Abstract: The invention refers to indole derivatives, process for preparation thereof, fungicidal composition and process for fungi control in the focus of infection.The indole derivative is represented by the general formula (1),( I )where R represents a substituted phenyl group;R3 and R4 independently represent a hydrogen or halogen atom, or an optionally substituted group: alkyl, alkoxy, cycloalkyl, phenyl or phenoxy;R5 and R6 independently represent a hydrogen atom or an optionally substituted group: alkyl, alkoxy, cycloalkyl, phenyl or phenoxy, or R5 and R6 together with the intermediary nitrogen atom represent a heterocyclyl group;R7 represents hydrogen atom or an alkyl group.
Patent AU-555755-B2 (AU)
Title: Bar code scanning head
Inventor: SHEPARD HOWARD M
IPC: G06K7/10
Filed: 1983-01-05
Granted: 1986-10-09
Abstract: A narrow-bodied, single-and twin-windowed, hand-held, laser scanning head for reading bar code symbols includes at least one window mounted at the rear region of the head, and through which either the incident beam going to the symbol and/or the reflected beam returning from the symbol, passes unobstructedly and exteriorly of, and past, the front and intermediate body regions of the head. A field- replaceable laser tube arrangement, a laser tube and method of making the same, an arrangement for and method of controlling a scanning system, optical passive elements for increasing the depth of field, a trigger protective device, and a one-piece support bench and method of fabricating the same by mass-production techniques are also disclosed.
Patent AU-692210-B2 (AU)
Title: Electrical installation equipment
Inventor: CATER RUDOLF
IPC: H02G3/08
Filed: 1995-02-24
Granted: 1998-06-04
Abstract: An electrical installation has a housing (20) with upper and lower parts and internal clips for holding electronic components and the necessary wiring. There are cable lead-ins on at least one side. Near them there is an open chamber (28), closed by a plate (31) containing the lead-in seals (35). The seals are made of soft elastic plastic, whereas the plate is made from hard plastic. The seals are grommets whose lips press against both sides of the plate. In plan view, the chamber lies below the terminal connectors (29). It can be extended by an additional cover plate. The plate is held in place by catches (32).
Patent AU-610147-B2 (AU)
Title: Pharmaceutical preparation
Inventor: RACKUR HELMUT
IPC: A61K47/00
Filed: 1988-04-05
Granted: 1991-05-16
Abstract: Known pharmaceutical preparations with iodine content in an (organic) solvent have high water contents. They cannot be stored for long times and often produce high local iodine concentrations in the application area, which result in skin irritations. They delay the operation due to their relatively slow evaporation, which is further uncomfortable for the patient due to the cooling effect. It is an object of the invention to overcome these disadvantages. The preparation according to the invention has only very small water content or is even completely non-aqueous. The preparation is storable for several years and evaporates very quickly on application without producing any excess local iodine concentrations. Unexpectedly, the non-aqueous preparation is thoroughly microbicidal in the 10-seconds range and further also kills spores quickly and with high efficiency.
Patent AU-665755-B2 (AU)
Title: Improved method and apparatus for sequentially stretching zero strain stretch laminate web to impart elasticity thereto without rupturing the web
Inventor: WEBER GERALD MARTIN
IPC: B32B5/24
Filed: 1992-01-28
Granted: 1996-01-18
Abstract: An improved method and apparatus for incrementally stretching "zero strain" stretch laminate webs to impart elasticity thereto in the direction of stretching, at least up to the point of initial stretching. The "zero strain" stretch laminate material is formed of at least two plies of material which are either intermittently or substantially continuously secured to one another along at least a portion of their coextensive surfaces while in a substantially untensioned ("zero strain") condition. One of the plies is stretchable and elastomeric, while the second ply is elongatable, but not necessarily elastomeric. The second ply will, upon stretching of the laminate, be at least to a degree permanently elongated so that, upon release of the applied tensile forces, it will not return to its original undistorted configuration. This results in z-direction bulking of the laminate web when the applied tension is released as well as subsequent elastic extensibility in the direction of initial stretching, at least up to the point of initial stretching. In a particularly preferred embodiment of the present invention, the mechanical stretching operation is carried out by passing said laminate web between multiple pairs of meshing corrugated rolls, each pair of rolls exhibiting a greater degree of meshing than the preceding pair, to sequentially stretch said web in stages. Sequentially stretching the web in the foregoing manner minimizes damage to the web.
Patent AU-626257-B2 (AU)
Title: Improved drive for banded washer type seal
Inventor: NOVOSAD EUGENE
IPC: F16J15/34
Filed: 1988-02-03
Granted: 1992-07-30
Abstract: An improved drive for a banded sealing ring or washer in a rotary mechanical seal. The washer, usually a ceramic washer, is provided with an annular band surrounding its outer periphery which includes an outwardly extending flange. The seal includes a sleeve mounted on a rotatable shaft of a pump, which houses the washer in coaxial relation. It further includes a flange extending radially, which defines means in contact with the band of the washer, such that driving engagement is effected between the sleeve flange and the washer band and the washer is caused to rotate with the sleeve.
Patent AU-554916-B2 (AU)
Title: Cable with adhesively bonded sheath
Inventor: GINDRUP WAYNE LAVAL
IPC: H01B11/18
Filed: 1983-07-18
Granted: 1986-09-04
Abstract: An electrical cable comprising a core having at least one inner conductor surrounded by a dielectric material, a metallic sheath surrounding said core, and an adhesive bonding said metallic sheath to said core, said adhesive comprising a water dispersible copolymer of ethylene and an ethylenically unsaturated carboxylic acid forming a thin film between said metallic sheath and said core.
Patent AU-781537-B2 (AU)
Title: Composition for treatment of burns
Inventor: DOSCH H MICHAEL
IPC: A61Q19/00
Filed: 1999-12-17
Granted: 2005-05-26
Abstract: The present invention is directed to a composition for treating burns. The composition comprises a therapeutically effective amount of one or more weak organic acid compatible with huamn skin, in a suitable carrier delivered at pH 4.0 - 4.5. The weak organic acid is preferably acetic acid, vinegar, or citric acid and the suitable carrier is preferably an aqueous based carrier, more preferably a gel form, utilizing a Carbopol<TM> as a gelling agent. The composition may also include one or more other agents selected from sun blocking agents, skin moisturizing agents and herb extracts.
Patent AU-732254-B2 (AU)
Title: A human cytomegalovirus combined antigen and its use
Inventor: BRUGGEMAN CATHARINA ANNA
IPC: G01N33/569
Filed: 1997-02-20
Granted: 2001-04-12
Abstract: A combined antigen having at least three portions of human cytomegalovirus (HCMV) proteins and characterized by an enhanced ability to bind HCMV-specific antibodies, for use in assays for the detection of HCMV-specific antibodies and as a vaccine to confer protective immunity against HCMV-mediated diseases.
Patent AU-733395-B2 (AU)
Title: Clot capture coil
Inventor: WENSEL JEFFREY P
IPC: A61B17/00
Filed: 1997-01-31
Granted: 2001-05-10
Abstract: A device for removing an obstruction in a blood vessel, the device comprising an obstruction engaging coil extending from an insertion element and being movable between a straightened arrangement and an expanded arrangement,  characterized in that  said obstruction engaging coil is formed of a superelastic material and is an elongate element with one end connected to the distal end of the insertion element and extending from the insertion element to a distal end, the obstruction engaging coil being naturally biased toward the straightened arrangement.
Patent AU-765103-B2 (AU)
Title: Method and device for preventing organism growth on sea-cases and sea water systems on ships, offshore platforms, etc
Inventor: SCHARF EVA-MARIA
IPC: B63B13/02
Filed: 2002-03-07
Granted: 2003-09-11
Abstract: The invention relates to a method and a device on ships, offshore-platforms, etc. for protecting against organism growth in complete seawater systems, operated on the basis of briefly raising the temperature of a volume of water (1) which is isolated by a mechanical closure system (4, 12). The brief temperature increase destroys the growth of organisms or their larvae without the need for toxic, environmentally damaging substances. Once the closure system has been opened, the normal cooling operation is resumed. The waste heat from the motor is used to raise the temperature for short periods of time. The mechanical closure of a sea-case is described as an application example. In cooling systems, comprising several circuits, joined by a mixing tank, each sub-circuit can be heated separately for a brief period, using the assembly of different heat exchangers and the integrated control and regulatory systems, thus preventing organism growth.
Patent AU-610936-B2 (AU)
Title: Antibiotic solutions of vancomycin hydrochloride and the lyophilization thereof
Inventor: ROBISON ROBERT LEE
IPC: A61K31/7042
Filed: 1988-10-13
Granted: 1991-05-30
Abstract: Gel-free concentrated aqueous formulations of vancomycin hydrochloride are provided which comprise the antibiotic salt at a concentration between about 12% and about 50% w/v and a gel-inhibiting compound, e.g., ethanol, at a concentration between about 1% and about 20% v/v. The gel-free formulations are especially useful in a freeze-drying process for preparing vancomycin hydrochloride as a dry flowable powder in bulk or in unit-dosage form.
Patent AU-756378-B2 (AU)
Title: Use of inhibitors for the treatment of disorders related to RTK hyperfunction, especially cancer
Inventor: ULLRICH AXEL
IPC: G01N33/15
Filed: 1999-01-22
Granted: 2003-01-09
Abstract: The invention provides method of diagnosing a receptor tyrosine kinase (RTK)-hyperfunction-induced disorder or a genetic predisposition therefor in a mammal. The method comprises determining the presence of a nucleic acid encoding a mutated fibroblast growth factor receptor-4 (FGFR-4) protein in a nucleic acid sample from a mammal. The presence of a nucleic acid encoding a mutated FGFR-4 protein is indicative of an RTK-hyperfunction-induced disorder or a genetic predisposition therefor.
Patent AU-747372-B2 (AU)
Title: Multiple watermarking techniques
Inventor: RHOADS GEOFFREY
IPC: H04N1/00
Filed: 1999-01-20
Granted: 2002-05-16
Abstract: Multiple digital watermarks, each of which has different characteristics, are embedded in a document. The characteristics of the various watermarks are chosen so that each of the watermarks will be affected in a different manner if the document is subsequently copied and reproduced.The detection process or mechanism reads each of the watermark and compares their characteristics. While wear and handling may change the characteristics of the digital watermarks in a document, the relationship between the characteristic of multiple digital watermarks in a document will never-the-less give an indication as to whether a document is an original or a copy of an original.
Patent AU-713581-B2 (AU)
Title: Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
Inventor: HELLBERG MARK R
IPC: A61P35/00
Filed: 1997-03-19
Granted: 1999-12-02
Abstract: PCT No. PCT/US97/04387 Sec. 371 Date Oct. 20, 1997 Sec. 102(e) Date Oct. 20, 1997 PCT Filed Mar. 19, 1997 PCT Pub. No. WO97/35852 PCT Pub. Date Oct. 2, 1997Compounds useful as cytoprotective agents are disclosed. The compounds possess dual activity, containing a phenolic portion selected to have antioxidant or free radical scavenging properties and a thiazolidine-4-carboxylate portion selected for its potential to act as a cysteine prodrug.
Patent AU-570477-B2 (AU)
Title: Dental implant with expanded ptfe gingival interface
Inventor: SCANTLEBURY TODD V
IPC: A61C8/00
Filed: 1984-06-27
Granted: 1988-03-17
Abstract: A dental implant device has a root structure (10) made of a biocompatible, mechanically suitable prosthetic material, a cervical segment (18) projecting above the root structure. made of a biocompatible, nonporous material and having smooth surfaces and together with the root structure forming a member; and a gingival interface (22) made of expanded polytetrafluoroethylene having a porous structureforthe ingrowth of connective tissue, located adjacent to the juncture of the root structure (10) and the cervical segment (18) attached to the member and forming a border around the apical end of the cervical segment. The expanded polytetrafluoroethylene provides for an interlocking between the gingival tissue and the pergingival portion of the dental implant preventing bacterial penetration and infection where the implant extends into the oral cavity.
Patent AU-750541-B2 (AU)
Title: Bis-biguanide antiplaque dentifrice exhibiting reduced staining
Inventor: CURTIS JOHN P
IPC: A61K8/43
Filed: 1999-03-11
Granted: 2002-07-18
Abstract: A dual component chlorhexidine dentifrice composition in which the first component contains a bis-biguanide antibacterial agent and the second component contains an abrasive incompatible with the bis-biguanide, wherein maximum antibacterial effect on dental tissue with reduced staining is achieved when the components and are physically separated prior to use and are mixed upon application to dental tissue.
Patent AU-572534-B2 (AU)
Title: Food intake suppressant substance
Inventor: KNOLL JOZSEF
IPC: A61K35/16
Filed: 1984-07-27
Granted: 1988-05-12
Abstract: The invention involves isolating a food intake suppressant by subjecting blood serum to ultrafiltration transmitting up to a molecular weight of 30,000 daltons, partially evaporating the filtrate, removing the insoluble part from the concentrate obtained, adding trichloroacetic acid up to a concentration of 5 to 25 weight/volume percent to the liquid phase at a temperature of 0 DEG to 10 DEG  C., removing the proteins precipitated, subjecting the obtained solution to chromatography on a gel with a void volume below a molecular weight of 4000 daltons, eluting with a solution of pH 6.0 to 7.0, concentrating the biologically active fractions, chromatographing again on a gel with a void volume below a molecular weight of 4000 daltons, fractionating by elution with water, lyophilizing the active fractions, dissolving the lyophilized fractions in a buffer of pH 8.1 to 8.2, adding trypsin and chymotrypsin to the solution in a substantially identical amount of 0.01 to 0.2 by weight as calculated for the total weight of the lyophilized product, subjecting the mixture to digestion at a temperature of 36 DEG  C. to 39 DEG  C., preferably with occasionally shaking from 20 to 30 hours, adding after the first 5 hours trypsin and chymotrypsin in a substantially half amount as calculated for the original enzyme quantity and continuing the digestion, then adding trichloroacetic acid to the reaction mixture up to a concentration of 4 to 6 weight/volume percent at a temperature between 0 DEG  and 10 DEG  C., keeping the mixture at a temperature between -15 DEG  C. and 5 DEG  C. for 1 to 24 hours, removing the insoluble part, subjecting the reaction mixture to chromatography on a gel with a void volume below a molecular weight of 4000 daltons, fractionating by elution with water and lyophilizing the biologically active fractions.
Patent AU-702917-B2 (AU)
Title: Cyclic hexapeptide somatostatin analogues
Inventor: MCBRIDE WILLIAM
IPC: C07K14/655
Filed: 1995-07-20
Granted: 1999-03-11
Abstract: This invention relates to therapeutic reagents and peptides, including radiotherapeutic reagents and peptides, and radiodiagnostic reagents and peptides. Specifically, the invention relates to cyclic peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods for using such peptides for radiodiagnostic and radiotherapeutic purposes.
Patent AU-710583-B2 (AU)
Title: Gene-Containing Compositions
Inventor: TSUKAMOTO MAKOTO
IPC: A61K9/133
Filed: 1995-08-31
Granted: 1999-09-23
Abstract: A genetic material containing composition comprising genes and a transporter that can transfer the same from the maternal body to the fetal cells. The composition, when administered to the maternal body, serves to prevent the birth of children suffering from gene deletion and to cure gene deletion during gestation. It is also possible by conducting an animal experiment for introducing unknown genes in an embryonal stage to clarify the function to be performed by the same in development. The composition c <IMAGE>
Patent AU-690344-B2 (AU)
Title: Curable coating compositions containing carbamate additives
Inventor: MENOVCIK GREGORY G
IPC: C09D161/28
Filed: 1995-11-02
Granted: 1998-04-23
Abstract: Curable coating compositions are described comprising   (a) a polymer resin comprising active hydrogen-containing functional groups other than carbamate, (b) a curing agent having groups that are reactive with said functional groups on (a), and (c) a compound having a molecular weight of from 75 to 2000 comprising at least one group of the formula:   <CHEM> wherein X is O or NH and either (a), (b), or both (a) and (b) comprise groups that are reactive with said group on (c).
Patent AU-622679-B2 (AU)
Title: Method upon a temperature increase of counteracting a viscosity decrease or providing a viscosity increase in a water-base system containing a polymer as viscosity agent
Inventor: CARLSSON ANDERS
IPC: A23L5/10
Filed: 1989-05-16
Granted: 1992-04-16
Abstract: The invention relates to a method in a water-base system for at least partially avoiding an expected viscosity decrease or providing a viscosity increase upon a temperature increase, by using a system containing as viscosity-adjusting agents a nonionic cellulose ether in such an amount that the aqueous solution thereof has a viscosity of 10-10,000 cP, measured according to Brookfield LV, 12 rpm at 20 DEG C, and an ionic surface-active compound in an amount of 1-30 mmol per litre of water.
Patent AU-767460-B2 (AU)
Title: Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
Inventor: PLACHTER BODO
IPC: C12N7/01
Filed: 2000-03-02
Granted: 2003-11-13
Abstract: This invention relates to viral particles which are released by mammal cells after the infection with human cytomegalovirus (HCMV). The invention also relates to particles whose antigenicity has been optimized by changing the HCMV using genetic engineering. The invention further relates to the use of such particles as a vaccine and a method for multiplying the HCMV in mammal cells.
Patent AU-696812-B2 (AU)
Title: Cardioplegia catheter system
Inventor: GOAR FREDERICK G ST
IPC: A61M25/06
Filed: 1995-11-21
Granted: 1998-09-17
Abstract: A catheter system is provided for accessing the coronary ostia transluminally from a peripheral arterial access site, such as the femoral artery, and for inducing cardioplegic arrest by direct infusion of cardioplegic solution into the coronary arteries. In a first embodiment, the catheter system is in the form of a single perfusion catheter with multiple distal branches for engaging the coronary ostia. In a second embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single arterial cannula. In a third embodiment, multiple perfusion catheters are delivered to the coronary ostia through a single guiding catheter. In a fourth embodiment, multiple catheters are delivered to the coronary ostia through a single guiding catheter which has distal exit ports that are arranged to direct the perfusion catheters into the coronary ostia. In each embodiment, the catheters are equipped with an occlusion means at the distal end of the catheter for closing the coronary ostia and isolating the coronary arteries from the systemic blood flow. The occlusion means can take the form of an inflatable occlusion balloon cuff, a tapered occlusion device or an O-ring encircling the distal end of the catheter. An optional ventricular venting catheter can be included in the system for venting blood and fluids from the left ventricle of the heart. The catheter system is combined with a femoral-to-femoral cardiopulmonary bypass system to provide a system for cardioplegic arrest and total cardiopulmonary support during minimally invasive cardiac surgical procedures.
Patent AU-674690-B2 (AU)
Title: 7-(substituted)-9-{(substituted glycyl)amido}-6-demethyl-6- deoxytetracyclines
Inventor: SUM PHAIK-ENG
IPC: C07C/
Filed: 1993-08-12
Granted: 1997-01-09
Abstract: The invention provides compounds of the formula: <CHEM> wherein R, R<3>, R<4> and W are defined in the specification. These compounds are useful as antibiotic agents.